{"id": "article-31737_0", "title": "EMS High-Altitude Field Prophylaxis And Treatment -- Introduction", "content": "The three\u00a0illnesses associated with\u00a0an ascent to altitudes 8,000 ft (high altitude) or more above sea level include: Acute mountain sickness (AMS) High-altitude cerebral edema (HACE) High-altitude pulmonary edema (HAPE)", "contents": "EMS High-Altitude Field Prophylaxis And Treatment -- Introduction. The three\u00a0illnesses associated with\u00a0an ascent to altitudes 8,000 ft (high altitude) or more above sea level include: Acute mountain sickness (AMS) High-altitude cerebral edema (HACE) High-altitude pulmonary edema (HAPE)"}
{"id": "article-31737_1", "title": "EMS High-Altitude Field Prophylaxis And Treatment -- Introduction", "content": "These represent a spectrum of diseases with similar pathophysiology but increasing severity. Successful treatment of these conditions\u00a0requires accurate recognition and prompt response.\u00a0 The Wilderness Medical Society (WMS) publishes regularly updated evidence-based guidelines for treatment. [1] This article summarizes the guidelines in a way that is\u00a0helpful for first responders and medical personnel responding to these high-altitude emergencies.", "contents": "EMS High-Altitude Field Prophylaxis And Treatment -- Introduction. These represent a spectrum of diseases with similar pathophysiology but increasing severity. Successful treatment of these conditions\u00a0requires accurate recognition and prompt response.\u00a0 The Wilderness Medical Society (WMS) publishes regularly updated evidence-based guidelines for treatment. [1] This article summarizes the guidelines in a way that is\u00a0helpful for first responders and medical personnel responding to these high-altitude emergencies."}
{"id": "article-31737_2", "title": "EMS High-Altitude Field Prophylaxis And Treatment -- Issues of Concern", "content": "Diagnosis and treatment of high-altitude illnesses present\u00a0several unique challenges. First, modern technology makes it possible, even for inexperienced climbers, to travel from sea level to high altitude in a short duration of time. Such rapidity of ascent generally makes acclimatization difficult. Furthermore, untrained climbers\u00a0could have comorbidities that might mimic, mask, or aggravate symptoms of high-altitude illness. Moreover, common travel-related illnesses, such as\u00a0dehydration and infections such as pneumonia or\u00a0food poisoning, could co-exist, further confounding the clinical picture. Such challenges could be overcome by a thorough\u00a0understanding of the signs, symptoms, and pathophysiology of high-altitude illnesses, as described below. [2]", "contents": "EMS High-Altitude Field Prophylaxis And Treatment -- Issues of Concern. Diagnosis and treatment of high-altitude illnesses present\u00a0several unique challenges. First, modern technology makes it possible, even for inexperienced climbers, to travel from sea level to high altitude in a short duration of time. Such rapidity of ascent generally makes acclimatization difficult. Furthermore, untrained climbers\u00a0could have comorbidities that might mimic, mask, or aggravate symptoms of high-altitude illness. Moreover, common travel-related illnesses, such as\u00a0dehydration and infections such as pneumonia or\u00a0food poisoning, could co-exist, further confounding the clinical picture. Such challenges could be overcome by a thorough\u00a0understanding of the signs, symptoms, and pathophysiology of high-altitude illnesses, as described below. [2]"}
{"id": "article-31737_3", "title": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance", "content": "At\u00a0higher altitudes,\u00a0there is a decrease in atmospheric pressure. This situation causes the partial pressure of inspired oxygen to decrease. Decreased partial pressures decrease the driving pressure for gaseous exchange in the lungs, leading to hypoxemia. \u00a0In response to this hypoxemia, the human body makes several physiologic changes to adapt to the new normal. \u00a0This process is known as acclimatization. Very rapid ascent, intrinsic poor hypoxic ventilatory response, and low vital capacity lead to inadequate acclimatization. The symptoms resulting from this mostly manifest at altitudes greater than 8,000 feet, which is\u00a0the reason why altitudes greater than 8,000 ft are known as \"high altitude.\" [3] (Commercial airliners\u00a0maintain\u00a0cabin pressures below 8,000 ft\u00a0for preventing altitude illness amongst the passengers and crew.)", "contents": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance. At\u00a0higher altitudes,\u00a0there is a decrease in atmospheric pressure. This situation causes the partial pressure of inspired oxygen to decrease. Decreased partial pressures decrease the driving pressure for gaseous exchange in the lungs, leading to hypoxemia. \u00a0In response to this hypoxemia, the human body makes several physiologic changes to adapt to the new normal. \u00a0This process is known as acclimatization. Very rapid ascent, intrinsic poor hypoxic ventilatory response, and low vital capacity lead to inadequate acclimatization. The symptoms resulting from this mostly manifest at altitudes greater than 8,000 feet, which is\u00a0the reason why altitudes greater than 8,000 ft are known as \"high altitude.\" [3] (Commercial airliners\u00a0maintain\u00a0cabin pressures below 8,000 ft\u00a0for preventing altitude illness amongst the passengers and crew.)"}
{"id": "article-31737_4", "title": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance", "content": "Acute Mountain Sickness (AMS) AMS\u00a0is the most benign\u00a0of the three altitude illnesses but must be recognized early because it has\u00a0the potential to\u00a0progress to life-threatening High Altitude Cerebral Edema\u00a0(HACE). About 25% of all travelers ascending to above 11,500 ft will experience AMS. [4] A\u00a0previous history of AMS is a\u00a0risk\u00a0factor for future episodes and, therefore, an indication for precaution. AMS Diagnosis: Headache plus one other symptom", "contents": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance. Acute Mountain Sickness (AMS) AMS\u00a0is the most benign\u00a0of the three altitude illnesses but must be recognized early because it has\u00a0the potential to\u00a0progress to life-threatening High Altitude Cerebral Edema\u00a0(HACE). About 25% of all travelers ascending to above 11,500 ft will experience AMS. [4] A\u00a0previous history of AMS is a\u00a0risk\u00a0factor for future episodes and, therefore, an indication for precaution. AMS Diagnosis: Headache plus one other symptom"}
{"id": "article-31737_5", "title": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance", "content": "The typical history for AMS is that of a low altitude dweller traveling to and exerting himself at high altitudes (most often above 8,000 ft). [5] It is diagnosed clinically by the\u00a0presence of a headache AND at least one of the following\u00a0symptoms: lack of appetite, nausea, vomiting, insomnia, dizziness, and/or fatigue. \u00a0These\u00a0symptoms will range from\u00a0mild to incapacitating (Severe AMS).\u00a0 Symptoms usually begin 6 to 12 hours after traveling to\u00a0altitude but may manifest sooner at 1 or 2 hours only. \u00a0Symptoms\u00a0are generally self-limiting, lasting 24 to 48 hours.\u00a0 However, in\u00a0less than 1% of cases, AMS may\u00a0progress to become HACE. [6] AMS Prophylaxis: gradual ascent plus acetazolamide Gradual Ascent The recommended method\u00a0for the\u00a0prevention of high-altitude illness\u00a0is to allow the body time to acclimatize\u00a0via gradual ascent. The WMS recommends one day of travel for every 1,500 ft ascent above 10,000 ft above sea level and a day of rest every 3 to 4 days of travel.", "contents": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance. The typical history for AMS is that of a low altitude dweller traveling to and exerting himself at high altitudes (most often above 8,000 ft). [5] It is diagnosed clinically by the\u00a0presence of a headache AND at least one of the following\u00a0symptoms: lack of appetite, nausea, vomiting, insomnia, dizziness, and/or fatigue. \u00a0These\u00a0symptoms will range from\u00a0mild to incapacitating (Severe AMS).\u00a0 Symptoms usually begin 6 to 12 hours after traveling to\u00a0altitude but may manifest sooner at 1 or 2 hours only. \u00a0Symptoms\u00a0are generally self-limiting, lasting 24 to 48 hours.\u00a0 However, in\u00a0less than 1% of cases, AMS may\u00a0progress to become HACE. [6] AMS Prophylaxis: gradual ascent plus acetazolamide Gradual Ascent The recommended method\u00a0for the\u00a0prevention of high-altitude illness\u00a0is to allow the body time to acclimatize\u00a0via gradual ascent. The WMS recommends one day of travel for every 1,500 ft ascent above 10,000 ft above sea level and a day of rest every 3 to 4 days of travel."}
{"id": "article-31737_6", "title": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance", "content": "Acetazolamide (125mg PO every 12 hours) Acetazolamide is the only medication proven to speed acclimatization. It induces metabolic acidosis by bicarbonate diuresis. This acidosis triggers compensatory hyperventilation helping acclimatization. There are two adverse effects of this medication worth considering. \u00a0First, acetazolamide\u00a0increases urination\u00a0frequency and therefore\u00a0increases the risk of\u00a0dehydration, which is a concern during high altitude travel [7] . \u00a0Secondly, acetazolamide has a similar molecular structure to sulfa medications and should be used cautiously in patients with sulfa allergy. \u00a0Although the risk of cross-reactivity\u00a0is low,\u00a0travelers\u00a0with sulfa allergies are recommended to\u00a0undergo a trial of acetazolamide before travel. [8] [9] Dexamethasone (4mg PO, IM, or IV every 12 hours)", "contents": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance. Acetazolamide (125mg PO every 12 hours) Acetazolamide is the only medication proven to speed acclimatization. It induces metabolic acidosis by bicarbonate diuresis. This acidosis triggers compensatory hyperventilation helping acclimatization. There are two adverse effects of this medication worth considering. \u00a0First, acetazolamide\u00a0increases urination\u00a0frequency and therefore\u00a0increases the risk of\u00a0dehydration, which is a concern during high altitude travel [7] . \u00a0Secondly, acetazolamide has a similar molecular structure to sulfa medications and should be used cautiously in patients with sulfa allergy. \u00a0Although the risk of cross-reactivity\u00a0is low,\u00a0travelers\u00a0with sulfa allergies are recommended to\u00a0undergo a trial of acetazolamide before travel. [8] [9] Dexamethasone (4mg PO, IM, or IV every 12 hours)"}
{"id": "article-31737_7", "title": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance", "content": "For those\u00a0unable to take acetazolamide,\u00a0dexamethasone may be\u00a0used as a preventive agent.\u00a0\u00a0It also may be considered for individuals\u00a0involved in an unusually high-risk situation (i.e., search and rescue personnel airlifted to above 11,000 ft). \u00a0Dosages for dexamethasone is the same for PO, IM, and IV routes of administration.\u00a0 If used for longer than ten days, it must be tapered slowly to prevent withdrawal symptoms. AMS Treatment: dexamethasone, with or without descent Dexamethasone (initial 8mg PO, IM, or IV followed in 6 hours by 4mg PO, IM, or IV every 6 hours) Dexamethasone is the medication of choice for the treatment of both AMS and HACE. It helps by decreasing vasogenic edema. NSAIDs in appropriate dosages may be added if the headache is debilitating.\u00a0 If taking dexamethasone for more than ten days, it requires tapering to prevent complications. Descent", "contents": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance. For those\u00a0unable to take acetazolamide,\u00a0dexamethasone may be\u00a0used as a preventive agent.\u00a0\u00a0It also may be considered for individuals\u00a0involved in an unusually high-risk situation (i.e., search and rescue personnel airlifted to above 11,000 ft). \u00a0Dosages for dexamethasone is the same for PO, IM, and IV routes of administration.\u00a0 If used for longer than ten days, it must be tapered slowly to prevent withdrawal symptoms. AMS Treatment: dexamethasone, with or without descent Dexamethasone (initial 8mg PO, IM, or IV followed in 6 hours by 4mg PO, IM, or IV every 6 hours) Dexamethasone is the medication of choice for the treatment of both AMS and HACE. It helps by decreasing vasogenic edema. NSAIDs in appropriate dosages may be added if the headache is debilitating.\u00a0 If taking dexamethasone for more than ten days, it requires tapering to prevent complications. Descent"}
{"id": "article-31737_8", "title": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance", "content": "Non-severe AMS:\u00a0Descent is not necessary for\u00a0non-severe AMS. It responds well to rest and/or\u00a0pharmacological treatment. If symptoms resolve, ascent may resume.Severe AMS is AMS with incapacitating symptoms. The\u00a0appropriate and definitive treatment for severe AMS is immediate descent to a lower altitude.", "contents": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance. Non-severe AMS:\u00a0Descent is not necessary for\u00a0non-severe AMS. It responds well to rest and/or\u00a0pharmacological treatment. If symptoms resolve, ascent may resume.Severe AMS is AMS with incapacitating symptoms. The\u00a0appropriate and definitive treatment for severe AMS is immediate descent to a lower altitude."}
{"id": "article-31737_9", "title": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance -- High-Altitude Cerebral Edema (HACE)", "content": "HACE is a medical emergency. \u00a0If untreated, the patient's condition will rapidly deteriorate, and death may occur within 12 to 24 hours. [10] A\u00a0previous history of HACE is a\u00a0risk\u00a0factor for future episodes and is an indication to take the proper precautions\u00a0for prevention. HACE Diagnosis: AMS plus neurologic symptoms", "contents": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance -- High-Altitude Cerebral Edema (HACE). HACE is a medical emergency. \u00a0If untreated, the patient's condition will rapidly deteriorate, and death may occur within 12 to 24 hours. [10] A\u00a0previous history of HACE is a\u00a0risk\u00a0factor for future episodes and is an indication to take the proper precautions\u00a0for prevention. HACE Diagnosis: AMS plus neurologic symptoms"}
{"id": "article-31737_10", "title": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance -- High-Altitude Cerebral Edema (HACE)", "content": "HACE most often\u00a0occurs at altitudes above 10,000 ft and is differentiated from AMS by the presence of neurologic symptoms. Ataxia is typically the earliest finding which may progress to lethargy, alteration of mental status, or even seizures. Without treatment, symptoms will rapidly worsen\u00a0and result in unconsciousness and death. Pathophysiology: Hypoxemia at higher altitudes causes dilatation of cerebral vasculature; this results in cerebral edema. HACE Prophylaxis: gradual ascent plus acetazolamide Gradual Ascent The recommended method\u00a0for the\u00a0prevention of high-altitude illness\u00a0is to allow the body time to acclimatize\u00a0via gradual ascent.\u00a0 The WMS recommends one day of travel for every 1,500 ft gained above 10,000 ft and a day of rest every 3 or 4 days.", "contents": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance -- High-Altitude Cerebral Edema (HACE). HACE most often\u00a0occurs at altitudes above 10,000 ft and is differentiated from AMS by the presence of neurologic symptoms. Ataxia is typically the earliest finding which may progress to lethargy, alteration of mental status, or even seizures. Without treatment, symptoms will rapidly worsen\u00a0and result in unconsciousness and death. Pathophysiology: Hypoxemia at higher altitudes causes dilatation of cerebral vasculature; this results in cerebral edema. HACE Prophylaxis: gradual ascent plus acetazolamide Gradual Ascent The recommended method\u00a0for the\u00a0prevention of high-altitude illness\u00a0is to allow the body time to acclimatize\u00a0via gradual ascent.\u00a0 The WMS recommends one day of travel for every 1,500 ft gained above 10,000 ft and a day of rest every 3 or 4 days."}
{"id": "article-31737_11", "title": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance -- Acetazolamide (125mg PO every 12 hours)", "content": "Acetazolamide is the only medication proven to assist with acclimatization to prevent AMS and HACE. \u00a0Reference the AMS section above for contraindications and adverse effects of this medication. HACE Treatment: descent from high altitude, plus dexamethasone, with or without supplemental oxygen, and with or without hyperbaric oxygen therapy (HBOT) by a portable chamber", "contents": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance -- Acetazolamide (125mg PO every 12 hours). Acetazolamide is the only medication proven to assist with acclimatization to prevent AMS and HACE. \u00a0Reference the AMS section above for contraindications and adverse effects of this medication. HACE Treatment: descent from high altitude, plus dexamethasone, with or without supplemental oxygen, and with or without hyperbaric oxygen therapy (HBOT) by a portable chamber"}
{"id": "article-31737_12", "title": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance -- Descent", "content": "Immediate evacuation to a lower altitude is the definitive treatment for both Severe AMS and HACE.\u00a0The target altitude\u00a0for descent depends upon clinical severity and response, but generally, symptoms\u00a0resolve\u00a0after\u00a01,000 ft to 3,000 ft drop in altitude. Dexamethasone (initial 8mg PO, IM, or IV followed in 6 hours by 4mg PO, IM, or IV every 6 hours) Dexamethasone is the medication of choice for the treatment of both AMS and HACE.\u00a0 It helps by decreasing cerebral edema. In cases of Severe AMS or HACE, dexamethasone should be used in conjunction with evacuation or while waiting for it. Supplemental Oxygen If available,\u00a0supplemental oxygen should\u00a0be administered with oxygen saturation of above 90% as a goal for both severe AMS and HACE. \u00a0Supplemental oxygen should only be used in conjunction with evacuation or while waiting for it. Portable Hyperbaric Chamber", "contents": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance -- Descent. Immediate evacuation to a lower altitude is the definitive treatment for both Severe AMS and HACE.\u00a0The target altitude\u00a0for descent depends upon clinical severity and response, but generally, symptoms\u00a0resolve\u00a0after\u00a01,000 ft to 3,000 ft drop in altitude. Dexamethasone (initial 8mg PO, IM, or IV followed in 6 hours by 4mg PO, IM, or IV every 6 hours) Dexamethasone is the medication of choice for the treatment of both AMS and HACE.\u00a0 It helps by decreasing cerebral edema. In cases of Severe AMS or HACE, dexamethasone should be used in conjunction with evacuation or while waiting for it. Supplemental Oxygen If available,\u00a0supplemental oxygen should\u00a0be administered with oxygen saturation of above 90% as a goal for both severe AMS and HACE. \u00a0Supplemental oxygen should only be used in conjunction with evacuation or while waiting for it. Portable Hyperbaric Chamber"}
{"id": "article-31737_13", "title": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance", "content": "These portable chambers are indicated for severe AMS and HACE when evacuation is delayed. \u00a0Symptoms will recur when the patient exits the chamber. However, it may temporarily improve symptoms long enough for patients to be able to assist with their evacuation. \u00a0The equipment and constant supervision make this a resource-intensive treatment, but it has the potential to save lives in remote areas where evacuation may be delayed.", "contents": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance. These portable chambers are indicated for severe AMS and HACE when evacuation is delayed. \u00a0Symptoms will recur when the patient exits the chamber. However, it may temporarily improve symptoms long enough for patients to be able to assist with their evacuation. \u00a0The equipment and constant supervision make this a resource-intensive treatment, but it has the potential to save lives in remote areas where evacuation may be delayed."}
{"id": "article-31737_14", "title": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance -- High-Altitude Pulmonary Edema (HAPE)", "content": "HAPE is the most common cause of fatality due to high altitude illness. [11] HAPE is a separate illness from AMS/HACE but\u00a0often\u00a0occurs simultaneously, confounding the clinical picture. HAPE Diagnosis: dyspnea at rest plus cough/rales/fever", "contents": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance -- High-Altitude Pulmonary Edema (HAPE). HAPE is the most common cause of fatality due to high altitude illness. [11] HAPE is a separate illness from AMS/HACE but\u00a0often\u00a0occurs simultaneously, confounding the clinical picture. HAPE Diagnosis: dyspnea at rest plus cough/rales/fever"}
{"id": "article-31737_15", "title": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance -- High-Altitude Pulmonary Edema (HAPE)", "content": "The typical history for HAPE is that of low altitude dwellers traveling to and exerting themselves\u00a0at altitudes above 8,000 ft. \u00a0Symptoms appear between 1-5\u00a0days of reaching altitude and begin\u00a0with dyspnea on exertion and nonproductive cough. \u00a0Over the next 24 to 48 hours, the symptoms progress to a productive cough and dyspnea at rest. \u00a0Clinical signs include tachycardia, tachypnea, fever, decreased pulse oximeter readings as compared to fellow travelers, and crackles on auscultation of lungs. Without treatment, symptoms will progress rapidly to respiratory arrest and death.", "contents": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance -- High-Altitude Pulmonary Edema (HAPE). The typical history for HAPE is that of low altitude dwellers traveling to and exerting themselves\u00a0at altitudes above 8,000 ft. \u00a0Symptoms appear between 1-5\u00a0days of reaching altitude and begin\u00a0with dyspnea on exertion and nonproductive cough. \u00a0Over the next 24 to 48 hours, the symptoms progress to a productive cough and dyspnea at rest. \u00a0Clinical signs include tachycardia, tachypnea, fever, decreased pulse oximeter readings as compared to fellow travelers, and crackles on auscultation of lungs. Without treatment, symptoms will progress rapidly to respiratory arrest and death."}
{"id": "article-31737_16", "title": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance -- High-Altitude Pulmonary Edema (HAPE)", "content": "Pathophysiology: Hypoxemia at high altitudes cause pulmonary vasculature to constrict to prevent ventilation-perfusion mismatch. This condition results in pulmonary hypertension and subsequent leakage from lung capillaries, eventually resulting in pulmonary edema. HAPE Prophylaxis: gradual ascent plus nifedipine Gradual Ascent The WMS recommends the same ascent profile as noted above for prevention of AMS/HACE, namely:\u00a0one day of travel for every 1,500 ft gained above 10,000 ft and a day of rest every 3 or 4 days. Nifedipine (30 mg extended-release PO every 12 hours) Preventative treatment using nifedipine is reserved for individuals with a history of HAPE. It helps by decreasing pulmonary hypertension. Dosing begins one day before ascent and is discontinued after four days at the highest point of ascent or beginning of the descent. HAPE Treatment: descend from high altitude, with or without supplemental oxygen, with or without HBOT using a portable chamber, with or without nifedipine", "contents": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance -- High-Altitude Pulmonary Edema (HAPE). Pathophysiology: Hypoxemia at high altitudes cause pulmonary vasculature to constrict to prevent ventilation-perfusion mismatch. This condition results in pulmonary hypertension and subsequent leakage from lung capillaries, eventually resulting in pulmonary edema. HAPE Prophylaxis: gradual ascent plus nifedipine Gradual Ascent The WMS recommends the same ascent profile as noted above for prevention of AMS/HACE, namely:\u00a0one day of travel for every 1,500 ft gained above 10,000 ft and a day of rest every 3 or 4 days. Nifedipine (30 mg extended-release PO every 12 hours) Preventative treatment using nifedipine is reserved for individuals with a history of HAPE. It helps by decreasing pulmonary hypertension. Dosing begins one day before ascent and is discontinued after four days at the highest point of ascent or beginning of the descent. HAPE Treatment: descend from high altitude, with or without supplemental oxygen, with or without HBOT using a portable chamber, with or without nifedipine"}
{"id": "article-31737_17", "title": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance -- High-Altitude Pulmonary Edema (HAPE)", "content": "Descend Altitude Evacuation to a lower altitude is the definitive treatment for HAPE. Descent goal is at least 1,000 ft but may require further descent until symptoms resolve.\u00a0Additional exercise\u00a0will worsen HAPE, so care should be taken to assist the patient in limiting exertion during descent. Supplemental Oxygen If available,\u00a0supplemental oxygen should\u00a0be administered with saturations of above 90% as a goal. Supplemental oxygen should be used in conjunction with evacuation or while waiting for\u00a0it. Portable Hyperbaric Chamber Portable chambers are indicated for the treatment of HAPE as a temporary measure when evacuation is delayed.\u00a0 Symptoms will recur when the patient exits the chamber. However, it may temporarily improve symptoms long enough for patients to be able to assist with their evacuation. The equipment and constant supervision makes this a resource-intensive treatment but has the potential to save lives in remote areas where evacuation may be delayed.", "contents": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance -- High-Altitude Pulmonary Edema (HAPE). Descend Altitude Evacuation to a lower altitude is the definitive treatment for HAPE. Descent goal is at least 1,000 ft but may require further descent until symptoms resolve.\u00a0Additional exercise\u00a0will worsen HAPE, so care should be taken to assist the patient in limiting exertion during descent. Supplemental Oxygen If available,\u00a0supplemental oxygen should\u00a0be administered with saturations of above 90% as a goal. Supplemental oxygen should be used in conjunction with evacuation or while waiting for\u00a0it. Portable Hyperbaric Chamber Portable chambers are indicated for the treatment of HAPE as a temporary measure when evacuation is delayed.\u00a0 Symptoms will recur when the patient exits the chamber. However, it may temporarily improve symptoms long enough for patients to be able to assist with their evacuation. The equipment and constant supervision makes this a resource-intensive treatment but has the potential to save lives in remote areas where evacuation may be delayed."}
{"id": "article-31737_18", "title": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance -- High-Altitude Pulmonary Edema (HAPE)", "content": "Nifedipine (30 mg extended-release PO every 12 hours) Nifedipine should only be used as a treatment option when evacuation becomes delayed or unavailable.", "contents": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance -- High-Altitude Pulmonary Edema (HAPE). Nifedipine (30 mg extended-release PO every 12 hours) Nifedipine should only be used as a treatment option when evacuation becomes delayed or unavailable."}
{"id": "article-31737_19", "title": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance -- Conclusion", "content": "Medical providers armed with the knowledge of prevention, diagnosis, and treatment of high-altitude illness shall be well-prepared for assisting with trip planning, and prevention, response, and\u00a0treatment of patients who travel to high-altitudes. The guidelines referenced in this article are a subject of ongoing research. The\u00a0Wilderness Medical Society provides guidance on high altitude medicine, which is updated regularly. [1]", "contents": "EMS High-Altitude Field Prophylaxis And Treatment -- Clinical Significance -- Conclusion. Medical providers armed with the knowledge of prevention, diagnosis, and treatment of high-altitude illness shall be well-prepared for assisting with trip planning, and prevention, response, and\u00a0treatment of patients who travel to high-altitudes. The guidelines referenced in this article are a subject of ongoing research. The\u00a0Wilderness Medical Society provides guidance on high altitude medicine, which is updated regularly. [1]"}
{"id": "article-31737_20", "title": "EMS High-Altitude Field Prophylaxis And Treatment -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "EMS High-Altitude Field Prophylaxis And Treatment -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}